Literature DB >> 6432710

Comparative study on the effects of acetylsalicylic acid, indomethacin and paracetamol on metabolites of arachidonic acid in plasma, serum and urine in man.

E Seppälä, O Laitinen, H Vapaatalo.   

Abstract

The effects of acetylsalicylic acid, indomethacin and paracetamol on the plasma and serum levels and the urinary excretion of arachidonic acid metabolites in man were demonstrated. The inhibition of prostaglandin synthesis was reflected better in the urinary excretions than in the plasma levels of arachidonic acid metabolites. A clear-cut reduction by acetylsalicylic acid and indomethacin in serum T X B2 can be reached within 24 h. Paracetamol had no uniform influence on the prostaglandins studied. The values returned to the initial level in seven days after indomethacin and in two weeks after acetylsalicylic acid treatment. In some cases a rebound overshoot in prostaglandin concentrations was observed after the discontinuation of the treatment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6432710

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Res        ISSN: 0251-1649


  4 in total

1.  Effects of diclofenac, indomethacin, tolfenamic acid and hydrocortisone on prostanoid production in healthy and rheumatic synovial cells.

Authors:  E Moilanen
Journal:  Agents Actions       Date:  1989-03

2.  Production of prostanoids by rheumatic synovial cells in vitro: effects of anti-inflammatory drugs on arachidonic acid metabolism.

Authors:  E Seppälä
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

Review 3.  Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action.

Authors:  Samir S Ayoub
Journal:  Temperature (Austin)       Date:  2021-03-16

4.  Pharmacokinetics of diclofenac and inhibition of cyclooxygenases 1 and 2: no relationship to the CYP2C9 genetic polymorphism in humans.

Authors:  Julia Kirchheiner; Ingolf Meineke; Nadine Steinbach; Christian Meisel; Ivar Roots; Jürgen Brockmöller
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.